Safety and Efficacy of Second-Line Metronomic Oral Vinorelbine-Atezolizumab Combination in Stage IV Non-Small-cell Lung Cancer: an Open-Label Phase II Trial (Vinmetatezo)
Lung cancer(2023)
关键词
Non-small cell lung cancer,Metastatic cancer,Vinorelbine,Atezolizumab,Immune check-point inhibitors,Phase II trial
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要